Status:

UNKNOWN

Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled Trial

Lead Sponsor:

Tianjin Medical University Eye Hospital

Collaborating Sponsors:

AbbVie

Conditions:

Diabetic Macular Edema

Pars Plana Vitrectomy

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Diabetic macular edema (DME) is the main cause of severe vision loss in diabetic retinopathy. Intravitreal injection of anti-vascular endothelial growth factor (VEGF) and Ozurdex are two safe and effe...

Eligibility Criteria

Inclusion

  • ≥18 years of age;
  • Patients and their families fully understand the research and must sign an informed consent form;
  • Patients have a history of diabetes and were diagnosed with PDR by ophthalmic examination;
  • Haemoglobin A1c (HbA1c) levels of \<10% within 3 months;
  • No contraindication of vitrectomy;
  • Pseudophakia or this operation is combined with phacoemulsification and lens implantation;
  • Diagnosed with DME by intraoperative optical coherence tomography during vitrectomy

Exclusion

  • The follow-up period is less than 6 months;
  • Patients need gas or silicon oil tamponade;
  • Patients with rubeosis iridis, neovascular glaucoma and endophthalmitis;
  • Patients with other intraocular surgeries (except cataract surgery with no ruptured posterior lens capsule);
  • Patients with other retinal diseases (i.e., age-related macular degeneration, retinal vein occlusion);
  • Patients received intravitreal Ozurdex three months prior to screening or anti-VEGF injection one month prior to screening;
  • Patients with uncontrolled systemic disease

Key Trial Info

Start Date :

October 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2025

Estimated Enrollment :

64 Patients enrolled

Trial Details

Trial ID

NCT05990829

Start Date

October 1 2023

End Date

April 1 2025

Last Update

March 6 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tianjin medical university eye hosipital

Tianjin, Tianjin Municipality, China